Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial

Background Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates. Purpose To assess the clinical and microbiological out...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical implant dentistry and related research 2021-08, Vol.23 (4), p.543-554
Hauptverfasser: Park, Seung‐Hyun, Song, Young Woo, Cha, Jae‐Kook, Lee, Jung‐Seok, Kim, Young‐Taek, Shin, Hyun‐Seung, Lee, Dong‐Won, Lee, Jae Hyun, Kim, Chang‐Sung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 554
container_issue 4
container_start_page 543
container_title Clinical implant dentistry and related research
container_volume 23
creator Park, Seung‐Hyun
Song, Young Woo
Cha, Jae‐Kook
Lee, Jung‐Seok
Kim, Young‐Taek
Shin, Hyun‐Seung
Lee, Dong‐Won
Lee, Jae Hyun
Kim, Chang‐Sung
description Background Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates. Purpose To assess the clinical and microbiological outcomes of administering metronidazole in combination with minocycline as a local adjunct to the nonsurgical treatment of peri‐implantitis. Materials and methods One hundred and eighteen subjects with peri‐implantitis were recruited in a four‐center, three‐arm, and 12‐week randomized controlled trial. Subjects were randomly assigned to receive one of the following treatments: (a) MM—mechanical debridement + metronidazole‐minocycline ointment, (b) MC—mechanical debridement + minocycline ointment, (c) NST—mechanical debridement only. Results Except for four subjects who was excluded during the trial, a total of 114 patients with 114 implants (one implant per each patient) finally completed the trial and were included in the analyses. Multivariate logistic regression analysis revealed that the treatment success rates (absence of bleeding or suppuration on probing, and sites showing pocket probing depth [PPD] ≥5 mm) on at 12 weeks were higher in MM‐group patients (31.6%) and MC‐group patients (20.5%) compared to NST‐group patients (2.7%; p = 0.011 and 0.040, respectively). Subjects with deepest PPD ≥8 mm showed a significant difference in the PPD reduction between MM and MC groups at week 4 (p = 0.025) and week 12 (p = 0.047). Detection ratio of Tannerella forsythia was significantly lower for MM group than MC group (p = 0.038). Conclusions Additive use of either MM or MC results in significantly higher treatment success rates compared to sole mechanical debridement in nonsurgical treatment of peri‐implantitis. Moreover, MM contributes to a significantly greater reduction in the PPD compared to MC in deep pockets (cris.nih.go.kr KCT0004557).
doi_str_mv 10.1111/cid.13006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2543446862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2543446862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3306-fc181f03254742654136ba2ec0b2640f5f6e9ee935b65db618358032258b764b3</originalsourceid><addsrcrecordid>eNp1kc9O3DAQxqOqSKWUA29gqZf2EPCf2Ov0tlpaQELqBc6R40zorBx7aztFy6mP0ANP2CfBkJ6QOpcZ6fvNNyN9VXXC6CkrdWZxOGWCUvWmOmQrqmvNqX5bZslFTXXbvqvep7SllDOm2GH1uB62s7cZfwGZE5AwkglyDB4H8xAc_P39Z0If7N469EVGnyfwmaAn-QcQH3ya4x1a40iOYBaxmOwgYtnFaeeMz5gxfSFrMs0uoy0IRBKNH8KEDzAQG3w56VwZc0TjPlQHo3EJjv_1o-r229ebzWV9_f3iarO-rq0QVNWjZZqNVHDZrBquZMOE6g0HS3uuGjrKUUEL0ArZKzn0imkhdcG51P1KNb04qj4tvrsYfs6QcjdhsuDKyxDm1BVj0TRKK17Qj6_QbZijL98VSgm1aqVWhfq8UDaGlCKM3S7iZOK-Y7R7zqcr-XQv-RT2bGHv0cH-_2C3uTpfNp4AMw-VwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2563679586</pqid></control><display><type>article</type><title>Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Park, Seung‐Hyun ; Song, Young Woo ; Cha, Jae‐Kook ; Lee, Jung‐Seok ; Kim, Young‐Taek ; Shin, Hyun‐Seung ; Lee, Dong‐Won ; Lee, Jae Hyun ; Kim, Chang‐Sung</creator><creatorcontrib>Park, Seung‐Hyun ; Song, Young Woo ; Cha, Jae‐Kook ; Lee, Jung‐Seok ; Kim, Young‐Taek ; Shin, Hyun‐Seung ; Lee, Dong‐Won ; Lee, Jae Hyun ; Kim, Chang‐Sung</creatorcontrib><description>Background Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates. Purpose To assess the clinical and microbiological outcomes of administering metronidazole in combination with minocycline as a local adjunct to the nonsurgical treatment of peri‐implantitis. Materials and methods One hundred and eighteen subjects with peri‐implantitis were recruited in a four‐center, three‐arm, and 12‐week randomized controlled trial. Subjects were randomly assigned to receive one of the following treatments: (a) MM—mechanical debridement + metronidazole‐minocycline ointment, (b) MC—mechanical debridement + minocycline ointment, (c) NST—mechanical debridement only. Results Except for four subjects who was excluded during the trial, a total of 114 patients with 114 implants (one implant per each patient) finally completed the trial and were included in the analyses. Multivariate logistic regression analysis revealed that the treatment success rates (absence of bleeding or suppuration on probing, and sites showing pocket probing depth [PPD] ≥5 mm) on at 12 weeks were higher in MM‐group patients (31.6%) and MC‐group patients (20.5%) compared to NST‐group patients (2.7%; p = 0.011 and 0.040, respectively). Subjects with deepest PPD ≥8 mm showed a significant difference in the PPD reduction between MM and MC groups at week 4 (p = 0.025) and week 12 (p = 0.047). Detection ratio of Tannerella forsythia was significantly lower for MM group than MC group (p = 0.038). Conclusions Additive use of either MM or MC results in significantly higher treatment success rates compared to sole mechanical debridement in nonsurgical treatment of peri‐implantitis. Moreover, MM contributes to a significantly greater reduction in the PPD compared to MC in deep pockets (cris.nih.go.kr KCT0004557).</description><identifier>ISSN: 1523-0899</identifier><identifier>EISSN: 1708-8208</identifier><identifier>DOI: 10.1111/cid.13006</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Antibiotics ; Clinical trials ; Debridement ; Dentistry ; Metronidazole ; Minocycline ; multicenter randomized controlled trial ; nonsurgical therapy ; Ointments ; Patients ; peri‐implantitis ; Regression analysis ; Success ; Transplants &amp; implants</subject><ispartof>Clinical implant dentistry and related research, 2021-08, Vol.23 (4), p.543-554</ispartof><rights>2021 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3306-fc181f03254742654136ba2ec0b2640f5f6e9ee935b65db618358032258b764b3</citedby><cites>FETCH-LOGICAL-c3306-fc181f03254742654136ba2ec0b2640f5f6e9ee935b65db618358032258b764b3</cites><orcidid>0000-0002-1410-9731 ; 0000-0003-1852-7989 ; 0000-0002-6906-7209 ; 0000-0002-5132-5783 ; 0000-0003-1835-5646 ; 0000-0003-1276-5978 ; 0000-0003-3902-1071 ; 0000-0003-2739-281X ; 0000-0002-6207-8036</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcid.13006$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcid.13006$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Park, Seung‐Hyun</creatorcontrib><creatorcontrib>Song, Young Woo</creatorcontrib><creatorcontrib>Cha, Jae‐Kook</creatorcontrib><creatorcontrib>Lee, Jung‐Seok</creatorcontrib><creatorcontrib>Kim, Young‐Taek</creatorcontrib><creatorcontrib>Shin, Hyun‐Seung</creatorcontrib><creatorcontrib>Lee, Dong‐Won</creatorcontrib><creatorcontrib>Lee, Jae Hyun</creatorcontrib><creatorcontrib>Kim, Chang‐Sung</creatorcontrib><title>Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial</title><title>Clinical implant dentistry and related research</title><description>Background Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates. Purpose To assess the clinical and microbiological outcomes of administering metronidazole in combination with minocycline as a local adjunct to the nonsurgical treatment of peri‐implantitis. Materials and methods One hundred and eighteen subjects with peri‐implantitis were recruited in a four‐center, three‐arm, and 12‐week randomized controlled trial. Subjects were randomly assigned to receive one of the following treatments: (a) MM—mechanical debridement + metronidazole‐minocycline ointment, (b) MC—mechanical debridement + minocycline ointment, (c) NST—mechanical debridement only. Results Except for four subjects who was excluded during the trial, a total of 114 patients with 114 implants (one implant per each patient) finally completed the trial and were included in the analyses. Multivariate logistic regression analysis revealed that the treatment success rates (absence of bleeding or suppuration on probing, and sites showing pocket probing depth [PPD] ≥5 mm) on at 12 weeks were higher in MM‐group patients (31.6%) and MC‐group patients (20.5%) compared to NST‐group patients (2.7%; p = 0.011 and 0.040, respectively). Subjects with deepest PPD ≥8 mm showed a significant difference in the PPD reduction between MM and MC groups at week 4 (p = 0.025) and week 12 (p = 0.047). Detection ratio of Tannerella forsythia was significantly lower for MM group than MC group (p = 0.038). Conclusions Additive use of either MM or MC results in significantly higher treatment success rates compared to sole mechanical debridement in nonsurgical treatment of peri‐implantitis. Moreover, MM contributes to a significantly greater reduction in the PPD compared to MC in deep pockets (cris.nih.go.kr KCT0004557).</description><subject>Antibiotics</subject><subject>Clinical trials</subject><subject>Debridement</subject><subject>Dentistry</subject><subject>Metronidazole</subject><subject>Minocycline</subject><subject>multicenter randomized controlled trial</subject><subject>nonsurgical therapy</subject><subject>Ointments</subject><subject>Patients</subject><subject>peri‐implantitis</subject><subject>Regression analysis</subject><subject>Success</subject><subject>Transplants &amp; implants</subject><issn>1523-0899</issn><issn>1708-8208</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kc9O3DAQxqOqSKWUA29gqZf2EPCf2Ov0tlpaQELqBc6R40zorBx7aztFy6mP0ANP2CfBkJ6QOpcZ6fvNNyN9VXXC6CkrdWZxOGWCUvWmOmQrqmvNqX5bZslFTXXbvqvep7SllDOm2GH1uB62s7cZfwGZE5AwkglyDB4H8xAc_P39Z0If7N469EVGnyfwmaAn-QcQH3ya4x1a40iOYBaxmOwgYtnFaeeMz5gxfSFrMs0uoy0IRBKNH8KEDzAQG3w56VwZc0TjPlQHo3EJjv_1o-r229ebzWV9_f3iarO-rq0QVNWjZZqNVHDZrBquZMOE6g0HS3uuGjrKUUEL0ArZKzn0imkhdcG51P1KNb04qj4tvrsYfs6QcjdhsuDKyxDm1BVj0TRKK17Qj6_QbZijL98VSgm1aqVWhfq8UDaGlCKM3S7iZOK-Y7R7zqcr-XQv-RT2bGHv0cH-_2C3uTpfNp4AMw-VwQ</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Park, Seung‐Hyun</creator><creator>Song, Young Woo</creator><creator>Cha, Jae‐Kook</creator><creator>Lee, Jung‐Seok</creator><creator>Kim, Young‐Taek</creator><creator>Shin, Hyun‐Seung</creator><creator>Lee, Dong‐Won</creator><creator>Lee, Jae Hyun</creator><creator>Kim, Chang‐Sung</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1410-9731</orcidid><orcidid>https://orcid.org/0000-0003-1852-7989</orcidid><orcidid>https://orcid.org/0000-0002-6906-7209</orcidid><orcidid>https://orcid.org/0000-0002-5132-5783</orcidid><orcidid>https://orcid.org/0000-0003-1835-5646</orcidid><orcidid>https://orcid.org/0000-0003-1276-5978</orcidid><orcidid>https://orcid.org/0000-0003-3902-1071</orcidid><orcidid>https://orcid.org/0000-0003-2739-281X</orcidid><orcidid>https://orcid.org/0000-0002-6207-8036</orcidid></search><sort><creationdate>202108</creationdate><title>Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial</title><author>Park, Seung‐Hyun ; Song, Young Woo ; Cha, Jae‐Kook ; Lee, Jung‐Seok ; Kim, Young‐Taek ; Shin, Hyun‐Seung ; Lee, Dong‐Won ; Lee, Jae Hyun ; Kim, Chang‐Sung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3306-fc181f03254742654136ba2ec0b2640f5f6e9ee935b65db618358032258b764b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics</topic><topic>Clinical trials</topic><topic>Debridement</topic><topic>Dentistry</topic><topic>Metronidazole</topic><topic>Minocycline</topic><topic>multicenter randomized controlled trial</topic><topic>nonsurgical therapy</topic><topic>Ointments</topic><topic>Patients</topic><topic>peri‐implantitis</topic><topic>Regression analysis</topic><topic>Success</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Park, Seung‐Hyun</creatorcontrib><creatorcontrib>Song, Young Woo</creatorcontrib><creatorcontrib>Cha, Jae‐Kook</creatorcontrib><creatorcontrib>Lee, Jung‐Seok</creatorcontrib><creatorcontrib>Kim, Young‐Taek</creatorcontrib><creatorcontrib>Shin, Hyun‐Seung</creatorcontrib><creatorcontrib>Lee, Dong‐Won</creatorcontrib><creatorcontrib>Lee, Jae Hyun</creatorcontrib><creatorcontrib>Kim, Chang‐Sung</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical implant dentistry and related research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Seung‐Hyun</au><au>Song, Young Woo</au><au>Cha, Jae‐Kook</au><au>Lee, Jung‐Seok</au><au>Kim, Young‐Taek</au><au>Shin, Hyun‐Seung</au><au>Lee, Dong‐Won</au><au>Lee, Jae Hyun</au><au>Kim, Chang‐Sung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial</atitle><jtitle>Clinical implant dentistry and related research</jtitle><date>2021-08</date><risdate>2021</risdate><volume>23</volume><issue>4</issue><spage>543</spage><epage>554</epage><pages>543-554</pages><issn>1523-0899</issn><eissn>1708-8208</eissn><abstract>Background Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates. Purpose To assess the clinical and microbiological outcomes of administering metronidazole in combination with minocycline as a local adjunct to the nonsurgical treatment of peri‐implantitis. Materials and methods One hundred and eighteen subjects with peri‐implantitis were recruited in a four‐center, three‐arm, and 12‐week randomized controlled trial. Subjects were randomly assigned to receive one of the following treatments: (a) MM—mechanical debridement + metronidazole‐minocycline ointment, (b) MC—mechanical debridement + minocycline ointment, (c) NST—mechanical debridement only. Results Except for four subjects who was excluded during the trial, a total of 114 patients with 114 implants (one implant per each patient) finally completed the trial and were included in the analyses. Multivariate logistic regression analysis revealed that the treatment success rates (absence of bleeding or suppuration on probing, and sites showing pocket probing depth [PPD] ≥5 mm) on at 12 weeks were higher in MM‐group patients (31.6%) and MC‐group patients (20.5%) compared to NST‐group patients (2.7%; p = 0.011 and 0.040, respectively). Subjects with deepest PPD ≥8 mm showed a significant difference in the PPD reduction between MM and MC groups at week 4 (p = 0.025) and week 12 (p = 0.047). Detection ratio of Tannerella forsythia was significantly lower for MM group than MC group (p = 0.038). Conclusions Additive use of either MM or MC results in significantly higher treatment success rates compared to sole mechanical debridement in nonsurgical treatment of peri‐implantitis. Moreover, MM contributes to a significantly greater reduction in the PPD compared to MC in deep pockets (cris.nih.go.kr KCT0004557).</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1111/cid.13006</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-1410-9731</orcidid><orcidid>https://orcid.org/0000-0003-1852-7989</orcidid><orcidid>https://orcid.org/0000-0002-6906-7209</orcidid><orcidid>https://orcid.org/0000-0002-5132-5783</orcidid><orcidid>https://orcid.org/0000-0003-1835-5646</orcidid><orcidid>https://orcid.org/0000-0003-1276-5978</orcidid><orcidid>https://orcid.org/0000-0003-3902-1071</orcidid><orcidid>https://orcid.org/0000-0003-2739-281X</orcidid><orcidid>https://orcid.org/0000-0002-6207-8036</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1523-0899
ispartof Clinical implant dentistry and related research, 2021-08, Vol.23 (4), p.543-554
issn 1523-0899
1708-8208
language eng
recordid cdi_proquest_miscellaneous_2543446862
source Wiley Online Library Journals Frontfile Complete
subjects Antibiotics
Clinical trials
Debridement
Dentistry
Metronidazole
Minocycline
multicenter randomized controlled trial
nonsurgical therapy
Ointments
Patients
peri‐implantitis
Regression analysis
Success
Transplants & implants
title Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A13%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adjunctive%20use%20of%20metronidazole%E2%80%90minocycline%20ointment%20in%20the%20nonsurgical%20treatment%20of%20peri%E2%80%90implantitis:%20A%20multicenter%20randomized%20controlled%20trial&rft.jtitle=Clinical%20implant%20dentistry%20and%20related%20research&rft.au=Park,%20Seung%E2%80%90Hyun&rft.date=2021-08&rft.volume=23&rft.issue=4&rft.spage=543&rft.epage=554&rft.pages=543-554&rft.issn=1523-0899&rft.eissn=1708-8208&rft_id=info:doi/10.1111/cid.13006&rft_dat=%3Cproquest_cross%3E2543446862%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2563679586&rft_id=info:pmid/&rfr_iscdi=true